Pharming Group N.V. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
Pharming Group N.V. (PHAR) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of $82.45 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-04-02
EUR
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2020-12-31 | 113.40M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | -15.36M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 18.78M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2025-12-31 | $82.45M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$4.59M 20-F · filed 2026-04-02 |
| 2023-12-31 | -$147.73M 20-F · filed 2026-04-02 |
| 2022-12-31 | $22.80M 20-F · filed 2025-04-03 |
| 2021-12-31 | -$11.41M 20-F · filed 2024-04-04 |
| 2020-12-31 | $128.68M 20-F · filed 2023-04-05 |
| 2019-12-31 | -$17.58M 20-F · filed 2022-04-06 |